Search

Theragnostic Imaging

Theragnostic Imaging

News
People
Events
Publications
RNTreg
Contact

Tim Illidge

Latest

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

© 2025 Me. This work is licensed under CC BY NC ND 4.0

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.